September 10, 2026
IRC Partners Research

What Key-Person Provisions Do Family Offices Require In a $15M+ Real Estate Joint Venture?

In This Article
Real estate joint venture agreement on a desk beside a development model, city skyline, and text about key-person provisions.
September 10, 2026

What Key-Person Provisions Do Family Offices Require In a $15M+ Real Estate Joint Venture?

Sponsors should limit key-person clauses to the principals whose loss would materially impair execution of the business plan, using objective triggers and a defined cure process. The agreement should preserve operational continuity, require timely LP responses to replacement candidates, and keep an uncured key-person event separate from automatic GP removal.

Key-person provisions define which individuals a family office LP considers essential to a joint venture's success, what events trigger a governance response, and what obligations the sponsor carries until a replacement is approved. In a $15M+ development JV, these provisions must be negotiated and documented before closing. A vague or one-sided key-person clause gives the LP a mechanism to suspend capital contributions, block major decisions, or initiate removal proceedings at the moment the sponsor is most vulnerable. Getting the designation, trigger, and cure language right in the JV agreement or LPA is a structural priority that must be resolved before closing.

Sponsors who have worked through how family offices evaluate key person risk in a first-time fund already understand the diligence lens. This article focuses on the drafting mechanics: which individuals should be named, which triggers to accept, how to cap continuity obligations, and what replacement mechanics protect the sponsor's operational authority during a cure period.

What a Family Office LP Means by "Key Person" in a Development JV

A key person, in the family office LP's framing, is the individual whose judgment, relationships, and execution capacity the LP relied on when committing capital. The designation is personal, not positional. A title like "Managing Partner" or "CEO" carries no automatic key-person status. The LP designates the people who actually sourced the deal, control the construction relationship, manage the lender, and handle LP communication.

In a development JV, family offices typically push to name a short, defined list of individuals. The most common designees are:

  • The principal who led the investment committee presentation and signed the term sheet
  • The project executive with direct authority over the general contractor and construction draws
  • The individual responsible for LP reporting and capital call management

The LP's goal is to ensure the people they underwrote are the people running the deal. That is a reasonable position. The sponsor's goal is to make sure the named list does not expand to include every senior team member, which would make routine personnel changes a governance event.

Which Individuals Sponsors Should and Should Not Accept as Designated Key Persons

Negotiating the designation list is one of the highest-leverage moments in the JV drafting process. Accepting the wrong individuals as key persons creates governance exposure for the life of the hold.

Individuals sponsors should accept as key persons

  • The GP principal with decision authority. If one person controls investment decisions, LP relationships, and capital deployment, naming that person is accurate and expected. Resisting it signals bad faith.
  • The project executive with construction authority. On a ground-up development, the individual managing the GC contract, draw schedule, and change order approvals is genuinely essential. Naming them is defensible and accurate.

Individuals sponsors should decline to name

  • Mid-level employees without decision authority. Naming a director of finance or a project manager as a key person gives the LP a governance trigger every time that role turns over.
  • Individuals whose departure would be routine. If a person's exit would be handled through a standard hiring process, they should not be in the key-person definition.
  • A broad list of individuals in a single JV. A designation list that extends beyond the principals with genuine decision authority is effectively a staffing covenant. Any departure, voluntary or involuntary, becomes a governance event requiring LP consent or cure.

Drafting principle: The key-person definition should name the individuals whose loss would materially impair the sponsor's ability to execute the business plan, and only those individuals.

The sponsor should propose the initial list, not accept the LP's first draft. Family offices often start with a broader designation than they actually need. A reasoned counter-proposal with role-specific justification is standard practice and rarely a deal-stopper.

What Events Trigger a Key-Person Clause and Which Triggers Create Control Risk

The trigger definition determines when the LP's key-person rights activate. Broad trigger language gives the LP a governance lever it can pull in circumstances the sponsor did not anticipate. Narrow trigger language limits the clause to genuine continuity events.

Standard triggers sponsors should accept

Trigger Why it is reasonable
Death or permanent disability of a named key person Genuine continuity event with no sponsor discretion
Voluntary resignation from the GP entity Direct loss of the individual the LP underwrite
Termination for cause Material breach of the operating agreement
Conviction of a felony Standard institutional LP requirement

Triggers that create control risk

  • "Devoting less than substantially all of their time" to the JV. This language is subjective and gives the LP a trigger any time a key person takes on additional responsibilities, manages a parallel project, or reduces hours during a construction delay. Sponsors should push for a specific percentage threshold, such as 75% of professional time, or a defined minimum hours standard.
  • "Material reduction in involvement" without a definition of material. Undefined materiality lets the LP argue a trigger occurred based on perception, not a measurable change.
  • Disability without a physician certification requirement. If the trigger activates on disability alone, the LP can assert it based on informal information. The document should require written certification from a licensed physician before the trigger is recognized.
  • Transfer of GP interest without LP consent. This is a legitimate LP protection, it should be scoped to controlling interest transfers, not internal restructuring between affiliated entities.

Key point: Sponsors should insist that every trigger in the key-person clause has a defined, objective standard. Subjective language is a governance risk that compounds over a multi-year hold.

Understanding how these trigger mechanics interact with the broader LP structure is part of what separates a well-negotiated JV from one that creates control problems mid-project. Sponsors choosing between deal-by-deal and blind pool structures will find that the governance expectations differ meaningfully between the two, and key-person trigger scope is one of the clearest examples of that difference.

How Continuity Obligations Should Be Scoped and Limited in the Document

After a key-person event is triggered, the JV agreement typically imposes continuity obligations on the sponsor. These obligations define what the GP must do to keep the project running while a cure or replacement process unfolds. Sponsors often accept these provisions without reading them carefully, which creates problems when an event actually occurs.

What continuity obligations typically require

  • Maintaining existing construction contracts and vendor relationships without modification above a defined dollar threshold
  • Continuing LP reporting on the standard quarterly schedule
  • Preserving cash management and draw approval processes
  • Refraining from entering new major contracts or commitments above a specified amount

These are reasonable. They protect the LP from the sponsor using the transition period to restructure the deal in ways the LP cannot monitor.

Where continuity obligations become overreaching

The risk is when continuity language expands into operational control. Watch for provisions that:

  • Require LP approval for any expenditure above a low threshold during the cure period (below the project's standard approval threshold)
  • Give the LP the right to appoint an observer or advisor with access to project accounts and contractor communications
  • Allow the LP to suspend capital contributions during the cure period without a corresponding obligation to fund critical construction draws

A suspended capital contribution during an active construction draw period can trigger a default with the senior lender. Sponsors should negotiate a carve-out requiring the LP to fund draws necessary to avoid a lender default, even if a key-person event is pending resolution.

The continuity obligation should preserve the status quo. It should not transfer operational decision-making to the LP during the cure window.

What Cure Periods and Replacement Mechanics Are Standard After a Key-Person Event

The cure period is the window the sponsor has to resolve a key-person event before the LP's remedial rights escalate. Standard practice in institutional JV agreements gives the sponsor a defined window, typically measured in weeks rather than months, to identify and present a replacement candidate. Some agreements allow a single extension if the sponsor demonstrates active progress, provided that extension is also defined in the document.

What the cure process should include

  • Written notice from the LP identifying the key-person event and the date it was triggered. The cure period should run from the date of written notice, not from the date the event occurred.
  • A sponsor-controlled search process. The sponsor should have the right to identify and propose the replacement, with the LP holding approval rights over the final candidate. The search process belongs to the sponsor. The LP holds approval authority over the final candidate only.
  • Defined LP approval standards. The LP's approval of a replacement candidate should be subject to a reasonableness standard, with a specific response window defined in the document. Silence after that window should be treated as approval to prevent the LP from blocking a replacement through inaction.
  • Interim authority during the cure period. The JV agreement should specify who holds decision authority during the cure window. Leaving this undefined creates an operational vacuum that the LP can exploit.

What happens if the cure period expires without resolution

If the sponsor cannot present an approved replacement within the cure period, the LP's remedial rights typically escalate. Common escalation paths include:

  • Suspension of the sponsor's right to make major decisions above a defined threshold
  • LP right to call a vote on GP replacement, subject to the removal mechanics in the operating agreement
  • Acceleration of distributions to the LP from available cash

The cure period should be long enough to conduct a real search. A development JV requires a replacement candidate with construction and LP-relationship experience. Sponsors should resist cure windows that do not allow enough time to identify, vet, and present a qualified candidate.

For context on how these replacement mechanics interact with the LP's broader removal rights, the ILPA Principles 3.0 provide a widely referenced framework for how institutional LPs approach key-person events and reinstatement procedures in fund documents.

How Key-Person Provisions Interact with Removal Rights and GP Replacement Language

Key-person provisions and removal rights are separate mechanisms, they share a boundary that sponsors must understand before signing. A key-person event activates a cure and replacement process. The LP's removal rights remain on a separate track. The two clauses carry different standards and different timelines.

The distinction that matters in drafting

A key-person event activates a cure and replacement process for a named individual. The GP entity remains in place. Removal of the GP entity is a separate action, governed by the removal clause, which typically requires a higher standard such as cause, gross negligence, or a supermajority LP vote.

The risk for sponsors is when the JV agreement allows an uncured key-person event to convert into a removal trigger. Language to watch for:

  • "Failure to cure a key-person event within the cure period shall constitute cause for GP removal"
  • "An uncured key-person event shall entitle the LP to exercise its removal rights without further notice"

These provisions collapse the two mechanisms into one, effectively giving the LP a removal path through the key-person clause without meeting the higher removal standard. Sponsors should resist any language that treats an uncured key-person event as automatic cause for removal.

What the document should say instead

An uncured key-person event should escalate LP rights within the JV (decision suspension, distribution acceleration) without automatically triggering removal. If the LP wants to pursue removal after an uncured key-person event, it should be required to satisfy the removal standard independently.

Sponsors raising $5M to $250M in institutional equity should treat the boundary between key-person and removal language as one of the most important governance issues in the operating agreement. Family offices that understand this distinction will often accept a clean separation. Those that push to merge the two mechanisms should be met with a clear counter-proposal and a reasoned explanation of why the separation protects both parties.

For a full treatment of what family offices look for before committing LP equity at this scale, the underwriting framework family offices use before a first LP commitment covers how governance structure factors into the allocation decision.

What Records and Governance Procedures Reduce Dispute Risk During the Hold

The key-person clause creates the framework. What happens during the hold determines whether that framework ever gets tested. Sponsors who maintain clean governance records throughout the project reduce the LP's ability to assert a key-person event based on ambiguous facts.

Records that matter most

  • Meeting minutes with attendance logs. If the JV agreement requires key persons to attend quarterly LP review meetings, minutes should document attendance by name. An LP that later claims a key person was effectively absent will have difficulty if attendance records contradict that claim.
  • Signed authorization records for major decisions. Draw approvals, change orders above the threshold, and vendor contract modifications should carry the signature of the designated key person. This creates a contemporaneous record of active involvement.
  • LP communication logs. Quarterly reports, capital call notices, and material update letters should be signed or attributed to the key person responsible for LP relations. If that person changes, the transition should be documented in writing and acknowledged by the LP.
  • Time allocation documentation. If the JV agreement includes a time-devotion standard for key persons, sponsors should maintain internal records showing how that standard is being met. This does not need to be a time sheet. A project role matrix updated quarterly is sufficient.

{{main-cta}}

Governance procedures that reduce dispute surface

  • Conduct a formal annual review of the key-person list and confirm in writing that all designated individuals remain in their roles with the same scope of authority.
  • Document any internal role changes that affect a named key person, even if the change does not rise to the level of a trigger. A written record showing the LP was informed of a role adjustment is far stronger than silence followed by a dispute.
  • Keep a single governance file for each JV that contains the operating agreement, key-person designation, all LP notices, and the cure-period correspondence log. If a dispute arises, this file is the first thing both sides will request.

Sponsors who treat governance documentation as a live function, rather than a closing-day exercise, rarely face key-person disputes that escalate to arbitration. The LP's ability to assert a trigger depends heavily on what the record shows.

What a Workable Key-Person Framework Looks Like Before Signing

A well-negotiated key-person framework has five components, all present in the signed document before closing:

  1. A named list of principals, each identified by role and function, limited to those whose loss would materially impair execution of the business plan, with no catch-all language expanding the definition to unnamed persons.
  2. Objective trigger standards, each with a defined threshold, a certification requirement where applicable, and no subjective materiality language.
  3. A cure period of sufficient length, running from written LP notice, with a sponsor-controlled search process and a defined LP approval window subject to a reasonableness standard. The ILPA Model LPA treats 90 days as the outer threshold before termination rights activate.
  4. Continuity obligations limited to status-quo preservation, with an explicit carve-out requiring LP capital contributions to continue for draws necessary to avoid a senior lender default.
  5. A clean separation between key-person events and GP removal, with no language allowing an uncured key-person event to convert into automatic cause for removal.

Sponsors who present this framework in the initial redline, rather than accepting the LP's first draft, negotiate from a stronger position. Family offices that have structured multiple JVs will recognize the framework as institutional-grade. Those that push back on every element are signaling a governance posture that will surface again during the hold.

IRC Partners works with sponsors raising $5M to $250M in institutional equity to structure JV agreements, LP operating agreements, and governance frameworks that hold up under family office diligence. If you are preparing to negotiate key-person language before signing, speaking with an advisor before the redline goes back is the right sequence.

Frequently Asked Questions

How many key persons should a family office JV agreement name?

The list should reflect the people whose loss would materially impair execution of the specific business plan, covering deal authority, construction oversight, and LP communication. Extending the designation beyond those principals creates a staffing covenant that turns routine personnel changes into governance events.

What is the difference between a key-person event and GP removal in a JV agreement?

A key-person event triggers a cure and replacement process for a named individual. The GP entity remains in place throughout that process. GP removal is a separate action governed by a higher standard, typically cause, gross negligence, or a supermajority LP vote. Sponsors should ensure the JV agreement keeps these two mechanisms on separate tracks, with no language allowing an uncured key-person event to convert into automatic cause for removal.

Can a family office LP suspend capital contributions after a key-person event?

Many JV agreements give the LP the right to suspend capital contributions during a cure period. Sponsors should negotiate a carve-out requiring the LP to fund draws necessary to avoid a default with the senior construction lender. A suspended draw during active construction can trigger a lender default regardless of the LP's internal governance dispute.

What time-devotion standard should sponsors accept for key persons?

Sponsors should push for a specific percentage threshold in place of vague language like "substantially all of their time." ILPA Principles 3.0 identifies an 80% time-commitment standard as the appropriate trigger threshold for key-person time-devotion provisions. A defined percentage is objective and measurable. Subjective language gives the LP a trigger whenever a key person takes on additional responsibilities or manages a parallel project, even if project performance is unaffected.

How long should the cure period be after a key-person event in a real estate JV?

The cure period should run from the date of written LP notice, not from the date the underlying event occurred. Sponsors should resist cure windows that do not allow enough time to identify, vet, and present a replacement candidate with the construction and LP-relationship experience a development project requires. The ILPA Model LPA uses 90 days as the outer threshold before termination rights activate, which provides a useful benchmark when negotiating the window length.

What happens if the LP refuses to approve a replacement candidate?

The JV agreement should require the LP's approval to be subject to a reasonableness standard, with a defined response window specified in the document. If the LP does not respond within that window, the agreement should treat silence as approval. Without this provision, the LP can block a replacement through inaction and allow the cure period to expire without a resolution the sponsor caused.

What governance records should sponsors maintain to reduce key-person dispute risk?

Sponsors should maintain quarterly meeting minutes with named attendance, signed authorization records for major decisions, LP communication logs attributed to the responsible key person, and a project role matrix showing how any time-devotion standard is being met. A single governance file per JV containing the operating agreement, key-person designation, all LP notices, and the cure-period correspondence log is the minimum standard for a hold of three years or longer.

Continue reading this series:

IRC Partners advises operators raising $5M to $250M of institutional capital on structure, positioning, and round architecture. We take seven strategic partners per quarter. No placement agent model. No success-only theater. Capital is raised on the strength of how the deal is built. If you want your current raise reviewed before it reaches the market and silently fails, apply here

Need guidance on your capital raise?

IRC Partners advises operators raising $5M to $250M of institutional capital. The Capital Raise Pre-Flight runs your deal through critical investor screening gates before any of them see it.
Book Your Pre-Flight Consult
Share this post:
Related Reading

Disclosure

The content published on this website is provided by IRC Partners (InvestorReadyCapital.com) for informational and educational purposes only. Nothing contained herein constitutes financial, investment, legal, or tax advice, nor should any content be construed as a solicitation, recommendation, or offer to buy or sell any security or investment product of any kind.

Nothing on this site constitutes an offer to sell, or a solicitation of an offer to purchase, any security under the Securities Act of 1933, as amended, or any applicable state securities laws. Any offering of securities is made only by means of a formal private placement memorandum or other authorized offering documents delivered to qualified investors.

IRC Partners is a capital advisory firm. IRC Partners is not a registered investment adviser under the Investment Advisers Act of 1940 and does not provide investment advice as defined thereunder.

Certain statements in this article may constitute forward-looking statements, including statements regarding market conditions, capital availability, investor demand, and transaction outcomes. Such statements reflect current assumptions and expectations only. Actual results may differ materially due to market conditions, regulatory developments, company-specific factors, and other variables. IRC Partners makes no representation that any outcome, return, or result described herein will be achieved.

References to prior mandates, transaction volume, network credentials, or capital raised are provided for illustrative purposes only and do not constitute a guarantee or prediction of future results. Past performance is not indicative of future outcomes. Individual results will vary. Network credentials and transaction statistics referenced on this site reflect the aggregate experience of IRC Partners' principals and affiliated advisors and are not a representation of assets managed or transactions closed solely by IRC Partners.

Certain data, statistics, and information presented in this article have been obtained from third-party sources. IRC Partners has not independently verified such information and expressly disclaims responsibility for its accuracy, completeness, or timeliness. Readers should independently verify any third-party data before relying on it.

Readers are strongly encouraged to consult qualified legal, financial, and tax professionals before making any investment, capital raising, or business decision.

Schedule A Meeting

You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.

We onboard a maximum of seven
 new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.